APA (7th ed.) Citation

Janić, M., Cankar, M., Šmid, J., France Štiglic, A., Jerin, A., Šabovič, M., . . . Lunder, M. (2022). Empagliflozin-Metformin Combination Has Antioxidative and Anti-Inflammatory Properties that Correlate with Vascular Protection in Adults with Type 1 Diabetes. Journal of Diabetes Research, 1-9. https://doi.org/10.1155/2022/6796470

Chicago Style (17th ed.) Citation

Janić, Miodrag, Matej Cankar, Jan Šmid, Alenka France Štiglic, Aleš Jerin, Mišo Šabovič, Andrej Janež, and Mojca Lunder. "Empagliflozin-Metformin Combination Has Antioxidative and Anti-Inflammatory Properties That Correlate with Vascular Protection in Adults with Type 1 Diabetes." Journal of Diabetes Research 2022: 1-9. https://doi.org/10.1155/2022/6796470.

MLA (8th ed.) Citation

Janić, Miodrag, et al. "Empagliflozin-Metformin Combination Has Antioxidative and Anti-Inflammatory Properties That Correlate with Vascular Protection in Adults with Type 1 Diabetes." Journal of Diabetes Research, 2022, pp. 1-9, https://doi.org/10.1155/2022/6796470.

Warning: These citations may not always be 100% accurate.
Visit our Citation Styles guide for help on properly citing sources.